Stormeur Group

community rating (0 votes):

Description

Discover how our commitment to excellence has made us a driving force in the Australian business landscape. At Stormeur, our values reflect our commitment to operating businesses that are driven by excellence and a focus on sustainable growth. We believe in fostering strong leadership and ensuring that our operations are aligned with the highest standards of compliance, safety, and customer care. Our approach is grounded in transparency and accountability, aiming to create value for our shareholders while delivering consistent returns. Through this commitment, we ensure that our business practices uphold integrity and align with long-term strategic goals.

website

Reviews

No Reviews Yet

Be the first to review one of our webinars!

Upcoming Webinars

There are no upcoming webinars on this topic or publisher.

Previous Webinars

Finance > Investing

Stormeur Group IPO Investor Webinar

Invest in Australia's First Accredited Cosmetic Clinic.We are pleased to announce the Offer for the IPO of Stormeur Ltd (ASX:STR), parent company of Cosmetique, is now open. Join Jane Morgan, Investor and Media Relations Manager and Vivek Eranki (Chairman) for a Company overview.Stormeur Ltd OverviewOperating as Cosmetique, Australia's first accredited cosmetic clinic, Stormeur Ltd has demonstrated remarkable success, including established a network of 17 clinics across five Australian states, offering high-quality, affordable cosmetic injectable treatments and laser hair removal services.Key Investment Highlights:• Rapidly expanding market: The Australian facial injectable market is projected to grow at a CAGR of 19.3% to reach USD 9.09 billion by 2030.• Proven business model: Cosmetique has provided over 300,000 treatments in the past year alone.• Strong growth strategy: Plans to open 4 new clinics in New South Wales and Victoria within 24 months of listing.• Industry-leading standards: First cosmetic injectables clinic in Australia to achieve NSQPCH accreditation.• Experienced management: Led by founder Dr. Vivek Eranki, with a track record of successful clinic rollouts.Offer closes 5:00pm (AWST) on 14 October 2024.